Latest News in the pharma Industry
Market News
Cambrex invests in generic API development and manufacturing capabilities at its Milan site
12 Oct 2017
Investments include the installation of development and analytical equipment to support the development of highly potent APIs.
Read more
New compact and high-speed powder filling
9 Oct 2017
Output of up to 480 vials per minute and the number of filling points can be individually selected.
Read more
Troubleshooting from a tablet manufacturer’s perspective
9 Oct 2017
I Holland to host a solutions-led seminar focusing on resolving tablet compression issues.
Read more
Rentschler Biotechnologie transitions into a European corporation called Rentschler Biopharma SE
9 Oct 2017
This legal form of company strengthens its position as a full-service CDMO and ensures its place as an industry leader.
Read more_Logo.jpg){kind=logo}
Boosting capabilities through collaboration
8 Oct 2017
CDMO, Micro-Sphere partners with German machine manufacturer Harro Höfliger for the latest step in its 21 million CHF (€19 million) investment into its facility in Switzerland.
Read more.jpg)
Bavarian Nordic secures contract award for supply of freeze-dried Imvamune smallpox vaccine to the US government
4 Oct 2017
Initial base award secures additional Imvamune bulk contract of USD 100 million.
Read more
Merck invests €35 million in its Italian biotech manufacturing site of Bari
4 Oct 2017
New production line for the aseptic filling of biotech medicines under isolator.
Read more
Tubilux selects TraceLink to achieve EU FMD Compliance
3 Oct 2017
By leveraging TraceLink’s network tenant architecture, Tubilux can eliminate the complexity and costs associated with point-to-point integrations for its EU pharmaceutical manufacturing customers.
Read more
Construction starts for Sartorius' new Cell Culture Technology Centre
2 Oct 2017
The 30-million-euro investment will accommodate the growing needs of customers.
Read more
PnuVax awarded $29.4 million grant to advance innovative vaccine into clinical trials
2 Oct 2017
Use of PnuVax’s unique patented conjugation platform technology to produce the vaccine is expected to speed up biomanufacturing and increase yield for a greatly reduced per-dose cost.
Read more
Preparing for the high potency boom
29 Sep 2017
Cambrex's new HP API facility in Charles City, Iowa - one of a limited number authorized by the US DEA to import narcotic raw materials at commercial scale - to offer clients complete flexibility across scale.
Read more
Cambrex opens new 'green' API manufacturing facility in Sweden
28 Sep 2017
Investments to increase capacity and support infrastructure ensure flexibility and efficiency to meet evolving customer needs.
Read more